TriangleHEALTH PROFESSIONAL · SOURCE READING
Targeted Therapy (Ceritinib)
Source: Childhood Mesothelioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 16, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Childhood Mesothelioma
In one case report, a 13-year-old patient with a peritoneal mesothelioma and a STRN::ALK fusion gene responded to ceritinib treatment.[9]
Source links and citations
For more information, see Malignant Mesothelioma Treatment.
Source links and citations
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice